logo

Has Tammy Baldwin taken steps to lower prescription drug prices?

By Tom Kertscher
YES

U.S. Sen. Tammy Baldwin, D-Wisconsin, has backed efforts to reduce prescription drug prices:

Cosponsored 2024 legislation to cap annual out-of-pocket costs at $2,000 per individual and $4,000 per family for people with private health insurance. No action has been taken.

Sent letters in January 2024 along with other senators to drug manufacturers demanding information on “exorbitant” asthma inhalers prices.

Sponsored 2023 legislation to require drug manufacturers to provide details of and justification for certain price increases. No action has been taken.

Supported the Inflation Reduction Act, which became law in 2022. It requires Medicare to negotiate the price of certain drugs.

Baldwin’s challenger in the Nov. 5, 2024, election, Republican Eric Hovde, stated that Baldwin "always talks about, 'I'm going to lower drug prices.' She's done nothing on that."

Average U.S. prescription drug prices are 2.78 times higher than in 33 other nations, the RAND think tank reported in February.

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Wisconsin Watch, the news arm of the nonpartisan, nonprofit Wisconsin Center for Investigative Journalism, increases the quality and quantity of investigative reporting in Wisconsin, while training current and future investigative journalists. Its work fosters an informed citizenry and strengthens democracy.
FACT BRIEF BY
facebook
twitter
email
email